Naproxen Cf (Naproxen)

Naproxen works by reversibly inhibiting the cyclooxygenase‑1 (COX‑1) and cyclooxygenase‑2 (COX‑2) enzymes. This inhibition blocks the conversion of arachidonic acid to prostaglandins, which are mediators of inflammation, pain, and fever. By lowering prostaglandin levels, naproxen reduces these symptoms at the site of tissue injury.

The dosage of Naproxen Cf is individualized by the prescribing clinician based on the specific indication, patient age, weight, renal function, and overall health status. The prescriber determines the appropriate strength, frequency, and duration of therapy, and patients should follow the written prescription without deviation.

Safety of naproxen in pregnancy and lactation has not been definitively established. It is generally avoided in the third trimester because of potential fetal cardiovascular effects. Women who are pregnant, planning pregnancy, or breastfeeding should discuss risks and alternatives with their healthcare provider before using naproxen.

To place an order, submit an enquiry on the Naproxen Cf product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team provides pricing, availability, shipping details (including any cold‑chain requirements), and assists with import documentation.

Both naproxen and ibuprofen belong to the NSAID class and share similar mechanisms of COX inhibition. Naproxen has a longer half‑life, allowing twice‑daily dosing for many patients, whereas ibuprofen often requires three to four doses per day. The choice between them depends on patient‑specific factors such as gastrointestinal tolerance, renal function, and the desired dosing schedule.

Naproxen Cf should be stored at room temperature, below 25 °C (77 °F). Keep the product in its original packaging, protect it from moisture, and store it away from direct sunlight or heat sources to maintain stability and potency.

Naproxen Cf is intended for oral administration. The tablets (or capsules, if applicable) should be swallowed whole with a full glass of water, preferably with food or milk to reduce gastrointestinal irritation, unless the prescribing information advises otherwise.

Serious adverse events include gastrointestinal bleeding or ulceration, severe renal impairment, cardiovascular events such as myocardial infarction or stroke, and rare but life‑threatening skin reactions like Stevens‑Johnson syndrome. Patients should be educated to seek immediate medical attention if they experience signs of bleeding, sudden kidney problems, chest pain, or severe skin rash.

Naproxen Cf is contraindicated in individuals with known hypersensitivity to naproxen or any NSAID, those with active gastrointestinal ulceration or bleeding, severe heart failure, and patients in the third trimester of pregnancy. Caution is also advised for patients with uncontrolled hypertension, significant renal or hepatic disease, and those taking anticoagulants without close monitoring.